TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Device Maker Threatens Legal Action Against Doctor Who Launched Campaign to End Power Morcellation September 5, 2014
TCL Archive Cancer society, In Major Restructure, Forms New Executive Committee, Bylaws November 20, 1992
